SCP Investment’s Medicines Co MDCO Stock Holding History

SCP Investment’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-25,000	Closed	-$684K	–	66
2017 Q4	$684K	Buy	+25,000	New	+$770K	0.71%	33

Other funds holding MDCO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

SCP Investment's MDCO Position: Q1 2018 in Review

SCP Investment sold out of Medicines Co (MDCO) in Q1 2018, closing a stake of 25,000 shares — an estimated $684K sold.

SCP Investment first reported a position in MDCO in Q4 2017 and held it in 1 quarter. The position peaked at $684K in Q4 2017. 190 funds tracked by Wall St. Rank hold MDCO as of Q1 2018.

SCP Investment reported no remaining Medicines Co position as of Q1 2018 after selling out during the quarter.
SCP Investment sold 25,000 Medicines Co shares in Q1 2018, an estimated $684K.
SCP Investment first reported a position in Medicines Co in Q4 2017 and held it in 1 quarter.
SCP Investment's Medicines Co position peaked at $684K in Q4 2017.
190 funds tracked by Wall St. Rank held Medicines Co as of Q1 2018.

Based on SCP Investment's 13F filing for Q1 2018, filed 15 May 2018.